{"filing":{"accession_number":"0001193125-26-282989","cik":"0001835022","ticker":"COYA","company_name":"Coya Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"d143621d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526282989/d143621d8k.htm"},"events":[{"id":13982,"run_id":12433,"accession_number":"0001193125-26-282989","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 discloses the final voting results from Coya Therapeutics' Annual Meeting of Stockholders held on June 25, 2026, including the election of two Class I directors (Secretary Wilbur Ross and Dieter Weinand) and ratification of Weaver and Tidwell, L.L.P. as independent auditor. The detailed vote tallies (For, Withheld, Broker Non-Votes, Against, Abstain) are the core disclosure required under Item 5.07 for shareholder meeting outcomes.","company_name":"Coya Therapeutics, Inc.","ticker":"COYA","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":11284,"accession_number":"0001193125-26-282989","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the final voting results from Coya Therapeutics' Annual Meeting of Stockholders held on June 25, 2026, including the election of two Class I directors (Secretary Wilbur Ross and Dieter Weinand) and ratification of Weaver and Tidwell, L.L.P. as independent auditor. The detailed vote tallies (For, Withheld, Broker Non-Votes, Against, Abstain) are the core disclosure required under Item 5.07 for shareholder meeting outcomes.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T21:01:45.551865+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11284,"accession_number":"0001193125-26-282989","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the final voting results from Coya Therapeutics' Annual Meeting of Stockholders held on June 25, 2026, including the election of two Class I directors (Secretary Wilbur Ross and Dieter Weinand) and ratification of Weaver and Tidwell, L.L.P. as independent auditor. The detailed vote tallies (For, Withheld, Broker Non-Votes, Against, Abstain) are the core disclosure required under Item 5.07 for shareholder meeting outcomes.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T21:01:45.551865+00:00","company_name":"Coya Therapeutics, Inc.","ticker":"COYA","filing_date":"2026-06-25"}]}